SFM
Sphera Funds Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.64M | Sell |
100,085
-167,300
| -63% | -$6.08M | 0.85% | 38 |
|
|
2025
Q1 | $9.68M | Buy |
267,385
+38,609
| +17% | +$1.4M | 2.23% | 8 |
|
|
2024
Q4 | $9.62M | Buy |
228,776
+33,427
| +17% | +$1.41M | 1.74% | 14 |
|
|
2024
Q3 | $10.9M | Sell |
195,349
-98,483
| -34% | -$5.47M | 1.73% | 17 |
|
|
2024
Q2 | $12.1M | Buy |
293,832
+55,288
| +23% | +$2.27M | 1.65% | 14 |
|
|
2024
Q1 | $11.1M | Buy |
238,544
+37,500
| +19% | +$1.75M | 1.56% | 18 |
|
|
2023
Q4 | $9.61M | Sell |
201,044
-58,091
| -22% | -$2.78M | 1.55% | 19 |
|
|
2023
Q3 | $9.24M | Buy |
259,135
+75,439
| +41% | +$2.69M | 1.68% | 10 |
|
|
2023
Q2 | $8.47M | Hold |
183,696
| – | – | 1.32% | 13 |
|
|
2023
Q1 | $7.37M | Hold |
183,696
| – | – | 1.23% | 23 |
|
|
2022
Q4 | $8.51M | Buy |
183,696
+10,000
| +6% | +$463K | 1.83% | 12 |
|
|
2022
Q3 | $7.19M | Buy |
+173,696
| New | +$7.19M | 1% | 26 |
|
|
2020
Q1 | – | Sell |
-115,000
| Closed | -$4.91M | – | 92 |
|
|
2019
Q4 | $4.91M | Buy |
+115,000
| New | +$4.91M | 0.4% | 50 |
|
|
2016
Q3 | – | Sell |
-105,000
| Closed | -$5.14M | – | 114 |
|
|
2016
Q2 | $5.14M | Buy |
+105,000
| New | +$5.14M | 1.33% | 16 |
|
|
2015
Q4 | – | Sell |
-30,700
| Closed | -$2.96M | – | 126 |
|
|
2015
Q3 | $2.96M | Sell |
30,700
-17,000
| -36% | -$1.64M | 0.38% | 53 |
|
|
2015
Q2 | $4.88M | Buy |
+47,700
| New | +$4.88M | 0.48% | 41 |
|